Abstract
Oral squamous cell carcinoma (OSCC) is a very aggressive malignant neoplasm, associated with high mortality rate. Despite the advances in OSCC treatment, the benefits in relation to OSCC prognosis have been disappointing so far and commonly, patients develop recurrence and resistance to therapy. Recent evidences demonstrated that OSCC contains a rare population of cells, called as Cancer …